Adam S. Feldman

Massachusetts General Hospital/Harvard Medical School

Dr. Adam S. Feldman is a faculty member of the Department of Urology and a Urologic Oncologist at Massachusetts General Hospital. He completed his residency in urology in 2006 and subsequently completed his fellowship in urologic oncology in June 2008. Dr. Feldman focuses his clinical practice in the treatment of prostate cancer, kidney cancer, bladder cancer and other genitourinary malignancies. He focuses his research interests on translational and clinical research in kidney, prostate and bladder cancers. He has received a Prostate Cancer Foundation Young Investigator Award for his work in novel biomarkers in prostate cancer and has been awarded a Physician Research Training Award by the Department of Defense (DOD). He is a co-PI on a DOD Synergistic Idea Development Award on the development of conditionally reprogrammed cells in prostate cancer, a co-investigator on an National Institutes of Health RO1 on metabolomic imaging in prostate cancer, and PI on a DOD Exploration Hypothesis Development Award investigating metabolomic imaging in renal masses. In addition to his translational research work in genitourinary cancer biomarkers, he has worked to develop clinical databases in active surveillance in prostate cancer, use of imaging and fusion biopsy in prostate cancer, surgical and ablative treatments for renal cell carcinoma, and renal mass biopsy. He is actively involved in the bladder cancer program and MGH and in assessing outcomes for patients with invasive and non-invasive disease.

Presentation(s):

Send Email for Adam Feldman